#4 "Estudio que no se ha hecho en niños pequeños dado que el covid no les afecta de manera grave, y es esa la razón por la que no se han desarrollado vacunas para ellos."
Children ages 5 through 11 years are eligible to receive the Pfizer-BioNTech COVID-19 vaccine.
Vaccine manufacturers are conducting clinical trials to assess the safety and efficacy of COVID-19 vaccination among children younger than 5 years old. Once completed, manufacturers submit applications to the U.S. Food and Drug Administration (FDA). FDA then reviews the submitted data and determines if vaccines are safe and effective and if they should be authorized for emergency use. Following FDA authorization, CDC’s Advisory Committee on Immunization Practices (ACIP) will meet to discuss making a recommendation to the CDC director on the use of authorized vaccines based on a thorough review of the available evidence. ACIP’s decision will be sent to the CDC director for review and the CDC director makes a final determination about the use of vaccine. If the CDC director recommends use of the vaccine, it will become available for administration.
#5 Que si, pero que se han testeado para mayores de 5 años en última instancia dada la afección leve en niños.
Era consciente de ello, vamos, que no es ningún contra-argumento, sino lo mismo que dije.
0k 10
Hemos deshabilitado la autenticación con Facebook. Si entras a Mediatize con una cuenta de Facebook, lee esto.
*
www.cdc.gov/vaccines/covid-19/planning/children.html
COVID-19 Vaccination Recommendations for Children Under 12
Children ages 5 through 11 years are eligible to receive the Pfizer-BioNTech COVID-19 vaccine.
Vaccine manufacturers are conducting clinical trials to assess the safety and efficacy of COVID-19 vaccination among children younger than 5 years old. Once completed, manufacturers submit applications to the U.S. Food and Drug Administration (FDA). FDA then reviews the submitted data and determines if vaccines are safe and effective and if they should be authorized for emergency use. Following FDA authorization, CDC’s Advisory Committee on Immunization Practices (ACIP) will meet to discuss making a recommendation to the CDC director on the use of authorized vaccines based on a thorough review of the available evidence. ACIP’s decision will be sent to the CDC director for review and the CDC director makes a final determination about the use of vaccine. If the CDC director recommends use of the vaccine, it will become available for administration.
Era consciente de ello, vamos, que no es ningún contra-argumento, sino lo mismo que dije.